Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cilo Cybin HoldingsJSE:CCC 7 Cash Ratio is 11.96 as of Sep. 2025, which is at its 10-year median of 11.96. GuruFocus rates JSE:CCC with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 975 Drug Manufacturers companies, Cilo Cybin Holdings ranks better than 96.92% on this metric.
Cilo Cybin Holdings has a Cash Ratio of 11.96. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Cilo Cybin Holdings's Cash Ratio or its related term are showing as below:
JSE:CCC'
s Cash Ratio Range Over the Past 10 Years
Min: 11.96 Med: 11.96 Max: 11.96
Current: 11.96
During the past 4 years, Cilo Cybin Holdings's highest Cash Ratio was 11.96. The lowest was 11.96. And the median was 11.96.
JSE:CCC's Cash Ratio is ranked better than 96.92% of 975
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs JSE:CCC: 11.96
Cilo Cybin Holdings (JSE:CCC) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Cilo Cybin Holdings Cash Ratio Related Terms
Cilo Cybin Holdings Cash Ratio Historical Data
* Premium members only.
The historical data trend for Cilo Cybin Holdings's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cilo Cybin Holdings Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Cilo Cybin Holdings's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cilo Cybin Holdings (JSE:CCC) has a Cash Ratio of 11.96 as of Sep. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cilo Cybin Holdings and its competitors. This is near median its historical median of 11.96. Over the past decade, Cilo Cybin Holdings' Cash Ratio has ranged from 11.96 to 11.96. According to the industry distribution chart, Cilo Cybin Holdings ranks #30 out of 975 companies in the Drug Manufacturers industry, placing it in the top 3.1%.
Is Cilo Cybin Holdings' Cash Ratio too high?
Cilo Cybin Holdings' current Cash Ratio of 11.96 is near median its 10-year median of 11.96. Over the past 10 years, this metric has ranged from a low of 11.96 to a high of 11.96. The Drug Manufacturers industry median Cash Ratio is 0.60. Cilo Cybin Holdings' value of 11.96 is 1893.3% above this industry median. Based on the distribution chart, Cilo Cybin Holdings ranks #30 out of 975 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cilo Cybin Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Cilo Cybin Holdings' Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cilo Cybin Holdings ranks #30 out of 975 companies for Cash Ratio. This places Cilo Cybin Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.60. Cilo Cybin Holdings' value of 11.96 is 1893.3% above this benchmark. Historically, Cilo Cybin Holdings' own Cash Ratio has ranged from 11.96 to 11.96 over the past decade. While the company's 10-year median is 11.96 vs. the industry median of 0.60, Cilo Cybin Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.60, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cilo Cybin Holdings's current Cash Ratio of 11.96 is 1893.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cilo Cybin Holdings and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cilo Cybin Holdings's current Cash Ratio is 11.96, which is near median its own 10-year median of 11.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cilo Cybin Holdings stock overvalued right now?
Cilo Cybin Holdings (JSE:CCC) has a current Cash Ratio of 11.96. The current Cash Ratio is 11.96, which is near median its 10-year median of 11.96 and 1893.3% above the Drug Manufacturers industry median of 0.60. Cilo Cybin Holdings' overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Cilo Cybin Holdings (JSE:CCC), the current Cash Ratio is 11.96 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cilo Cybin Holdings Ltd is engaged in identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses. It offers products and services in the medical cannabis sector.
7GF Score
Get the complete analysis for JSE:CCC
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:CCC has been successfully added to your 
